| Description |
Join us at New York City’s historic South Street Seaport for the 5th Annual Stem Cell Summit and be part of 2010’s premier gathering of stem cell company scientists, executives, and investors to focus on the commercialization of stem cell products.
It’s your chance to uncover the latest investment opportunities in the stem cell marketplace, evaluate the groundbreaking stem cell products that physicians are using today, and discover the growing market potential in terms of revenues.
Hear and meet the top stem cell industry leaders during this one-day event on February 16, 2010, at one of New York City’s finest venues, Bridgewaters, only minutes from the financial district. This is a limited-capacity event, so reserve your seat now. Plus, the earlier you register, the more you save. For more information and to register, visit www.stemcellsummit.com.
No company, surgeon or industry analyst can afford to miss this meeting. With more than 50 presentations by the stem cell therapy commercial and technology leaders, this is the most critical stem cell meeting of the year. Featuring:
• 6 major new stem cell therapies, all forecast to reach physicians and surgeon practitioners in 2010
• New allograft products, new forms of autologous stem cell technologies, and at least one FDA approved stem cell drug
• Major new studies showing rehydration of the disc nucleus, new heart muscle regeneration studies, and others
• 35 corporate presenters
• 300 attendees expected
• Unparalleled networking opportunities
• Presentations will include the description of a dramatic new source of stem cells―placental tissues
• Scientific panels, individual tracks for stem cells tools & instruments, and your personal copy of the annual Stem Cell Market Analysis & Forecast (2009-2019) containing profiles of the world’s top 50 stem cell companies
• And, of course, Robin Young’s updated 10-year forecast for the industry
|
|
